Delisting of Sorrento Therapeutics Inc (SRNE) on 21 February 2023 | Vantage UK

Important Information

Thank you for visiting the Vantage Markets website. Please note that this website is intended for individuals residing in jurisdictions where accessing it is permitted by Vantage and its affiliated entities do not operate in your home jurisdiction.

By clicking 'I CONFIRM MY INTENTION TO PROCEED AND ENTER THIS WEBSITE', you confirm that you are entering this website solely based on your initiative and not as a result of any specific marketing outreach. You wish to obtain information from this website based on reverse solicitation principles, in accordance with the applicable laws of your home jurisdiction.

I CONFIRM MY INTENTION TO PROCEED AND ENTER THIS WEBSITE

×

Celebrating 15 Years of Excellence

Find Out More >

CFDs and Spread Bets are complex instruments and come with a high risk of losing money rapidly due to leverage. 57.7% of retail investor accounts lose money when trading CFDs and Spread Bets with this provider. You should consider whether you understand how CFDs and Spread Bets work and whether you can afford to take the high risk of losing your money.

Risk Disclosure Notice

View More

SEARCH

All

Trading

Platforms

Academy

Analysis

Promotions

About
Search query too short. Please enter a full word or phrase.

Keywords

Notifications 17 Feb 2023

Delisting of Sorrento Therapeutics Inc (SRNE) on 21 February 2023

NOTIFICATIONS

Please be advised that due to the bankruptcy of Sorrento Therapeutics Inc (SRNE), this stock will be delisted from the Vantage trading platform.

This will take place as per the following schedule:

Effective Date: 21 February 2023

For the full press release, please refer here.

We have currently disable the trading of SRNE in our trading platform effective 17 February 2023.

If you have any questions or require assistance, please do not hesitate to contact [email protected] .

IN CASE YOU MISSED IT